Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Update on Current Trading

16 Jun 2020 07:00

RNS Number : 0272Q
4imprint Group PLC
16 June 2020
 

16 June 2020

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides a further update on the effect of the COVID-19 pandemic on the Group's trading and operations.

 

In our last COVID-19 update issued on 7 April 2020, we noted that the spread of the pandemic and associated 'Safer at Home' or similar directives had resulted in order counts reducing to about 20% of prior year level. As the partial or full lifting of these restrictions began in many US states in May and early June, weekly order counts have steadily increased and are now approaching 50% of the 2019 comparative. Importantly, we continue to acquire new customers and the new-to-existing customer ratio has remained broadly stable over this period.

 

Since the beginning of the pandemic, we have continued to provide excellent service to our customers through an expanded 'work from home' capability. Our two US locations in Oshkosh, Wisconsin and our office in Manchester, UK have now reopened. Where practical, however, team members continue to work from home, allowing us to implement robust social distancing protocols in our facilities. In line with our culture, the health, safety and wellbeing of our people remains our top priority, and we have continued to prioritise the retention of our team members throughout this difficult period. Our team is ready and very motivated to service the recovering demand that we are seeing.

 

Cash conservation was a clear focus for the Group early in the COVID-19 crisis. Action has been taken to control discretionary and capital spend. We executed a thoughtful and effective recalibration of the marketing strategy to significantly decrease marketing investment throughout the period yet stay connected with our existing customers and maintain our brand awareness. This strategy has also given us the flexibility to ramp up the marketing as justified by market conditions.

 

The Group's balance sheet and liquidity position remain strong. At the end of May 2020, the Group had cash balances of $28.1m, and no debt. This is after the payment in May of the $9.4m planned lump sum contribution to the Group's defined benefit pension plan. We also have a working capital facility of $20m.

 

The Group intends to announce its half year results for the 26 weeks ended 27 June 2020 on Thursday 13 August 2020. In the meantime, the Board remains confident in 4imprint's strategy, business model and market position, culminating in the delivery of longer-term value for all stakeholders.

 

 

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8100

 

Kevin Lyons-Tarr

Chief Executive Officer

 

David Seekings

Chief Financial Officer

Katie Hunt

 

 

Rachel Mann

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFSFWIESSEFM
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.